These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32966289)

  • 1. Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
    Rayner JE; Duffy DL; Smit DJ; Jagirdar K; Lee KJ; De'Ambrosis B; Smithers BM; McMeniman EK; McInerney-Leo AM; Schaider H; Stark MS; Soyer HP; Sturm RA
    PLoS One; 2020; 15(9):e0238529. PubMed ID: 32966289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients.
    Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1076-1083. PubMed ID: 30680790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
    Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
    BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.
    Nathan V; Johansson PA; Palmer JM; Howlie M; Hamilton HR; Wadt K; Jönsson G; Brooks KM; Pritchard AL; Hayward NK
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):854-863. PubMed ID: 31233279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.
    Hawkes JE; Cassidy PB; Manga P; Boissy RE; Goldgar D; Cannon-Albright L; Florell SR; Leachman SA
    J Dermatol Sci; 2013 Jan; 69(1):30-7. PubMed ID: 23103111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
    Preising MN; Forster H; Gonser M; Lorenz B
    Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism.
    Maas EJ; Wallingford CK; McGuire JJ; Rutjes C; Smit DJ; Betz-Stablein B; Sturm RA; Soyer HP; McInerney-Leo AM
    J Dermatol; 2022 Nov; 49(11):1183-1187. PubMed ID: 35894802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene.
    Morice-Picard F; Lasseaux E; Cailley D; Gros A; Toutain J; Plaisant C; Simon D; François S; Gilbert-Dussardier B; Kaplan J; Rooryck C; Lacombe D; Arveiler B
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):59-71. PubMed ID: 24118800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
    Nan H; Kraft P; Hunter DJ; Han J
    Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
    Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
    Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
    Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
    Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
    Hutton SM; Spritz RA
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
    Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
    PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
    Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
    BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.
    Emley A; Nguyen LP; Yang S; Mahalingam M
    Hum Pathol; 2011 Jan; 42(1):136-40. PubMed ID: 21056896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
    Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
    Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.